The following is a breakdown of the information researchers need about this powerful peptide. It has been speculated that BPC-157 may have favorable impacts on wound healing and tissue repair, tissue development, and even neuroprotection. An overview of the most important results from research conducted on BPC-157 will be presented in this guide, emphasizing the potential properties linked with the action of this peptide.
The pentadecapeptide known as BPC-157 comprises a string of fifteen different amino acids. The first time it was isolated was in 1991, and it is a fragment of the Body Protection Compound found naturally in gastrointestinal fluid. In particular, BPC-157 is well-researcherd for its allegedly curative and restorative characteristics on tissues, such as its potential to stimulate angiogenesis, which is the process by which new blood vessels are formed.
It is hypothesized that the mechanism of action for BPC-157 involves:
However, the exact mechanism of action for BPC-157 is yet unknown.
Studies suggest that BPC-157 may play a significant part in the functioning of the gastrointestinal system, where it may potentially aid in the context of various unpleasant illnesses, including Crohn's disease, gastrointestinal cramps, and leaky gut. Additionally, it has been suggested that BPC-157 may hasten the healing process in cases of tendon injuries and burns to the skin. This increases blood flow to the damaged regions, providing neuroprotective characteristics and accelerated muscle development.
It has been indicated in several studies that the presentation of BPC-157 may result in a variety of favorable outcomes, including the following:
It may maintain the integrity of the gastrointestinal tissues
Research indicates that BPC-157 may be an anti-ulcer peptidergic compound that "protects stomach cells and maintains gastric integrity," as suggested in a notable research study. Research conducted in laboratory settings has asserted that evaluating BPC-157 as a research agent may be relevant in the context of inflammatory bowel disease.
Several studies have purported that BPC-157 may enhance the recruitment of blood vessels, which might help restore the integrity of blood flow. It has been hypothesized that this may be done by upregulating vascular endothelial growth factor (VEGF). This protein increases the development of blood vessels and promotes the production of blood vessels via a process known as angiogenesis.
According to animal research, BPC-157 seems to have a modulatory influence on angiogenesis in the muscle and tendon repair process. According to the findings of an early investigation conducted on chicks, BPC-157 was purported to boost the generation of nitric oxide (NO) and assist in preventing the development of pulmonary hypertension syndrome and tissue lesions. Additionally, activating NO pathways might enhance energy levels.
One research study on rats indicates that BPC-157 may possess neuroprotective characteristics. In animals that have been subjected to prolonged stress, the peptide seems to not only heal nerve damage that has been induced by alcohol intoxication but also reduce or mitigate depressive-behaviors. In addition, research that was conducted in 2014 suggested that BPC-157 may have mitigated the severity of the detrimental effects that methamphetamine-induced neurotoxicity had on rats.
The skin, the heart, the liver, the pancreas, and the brain all seem to be protected by BPC-157 against "the adverse effects of alcohol and nonsteroidal anti-inflammatory drugs (NSAIDs)." A further study conducted in 2013 theorized that "BPC-157 may be used as an agent against NSAIDs", and there is still a significant amount of research interest in BPC-157 for this particular purpose, its non-approval for human and clinical employment not-withstanding.
It has been asserted that BPC-157 may have a beneficial impact on survival rates compared to placebo in trials involving mice with traumatic brain injury (TBI). Additionally, it has been hypothesized to lessen the amount of damage that occurs after the injury. Because of the possible angiogenic qualities of BPC-157, the peptide is specuated to speed up the healing process of wounds by increasing the amount of blood that flows to the damaged region.
BPC-157 has been theorized to have a strong anti-inflammatory impact on periodontal tissues in rats that had ligature-induced periodontitis. "BPC-157 significantly reduced both plasma extravasation and histological alterations, as well as alveolar bone resorption," and this was believed to be accomplished without having a detrimental impact on blood circulation, as suggested by the findings of the researchers.
Studies conducted in test tubes have suggested that BPC-157 may stimulate the production of growth hormone receptors. In addition to encouraging the development of bone, skin, and muscle cells, the presentation of this peptide is hypothesized to have the potential to stimulate the formation of new tissue.
Click here to be redirected to the Core Peptides website for more educational articles and high-quality research compounds.
References
[i] Chang, C. H., Tsai, W. C., Hsu, Y. H., & Pang, J. H. (2014). Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules (Basel, Switzerland), 19(11), 19066–19077.
[ii] Klicek, R., Sever, M., Radic, B., Drmic, D., Kocman, I., Zoricic, I., Vuksic, T., Ivica, M., Barisic, I., Ilic, S., Berkopic, L., Vrcic, H., Brcic, L., Blagaic, A. B., Coric, M., Brcic, I., Rokotov, D. S., Anic, T., Seiwerth, S., & Sikiric, P. (2008, September 25). Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: Role of the nitric oxide-system. Journal of Pharmacological Sciences.
[iii] Sikiric P, Hahm KB, Blagaic AB, Tvrdeic A, Pavlov KH, Petrovic A, Kokot A, Gojkovic S, Krezic I, Drmic D, Rucman R, Seiwerth S. Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future. Gut Liver. 2020 Mar 15;14(2):153-167. doi: 10.5009/gnl18490. PMID: 31158953; PMCID: PMC7096228.
[iv] Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009 Dec;60 Suppl 7:191-6. PMID: 20388964.
[v] Grabarevic Z, Tisljar M, Artukovic B, Bratulic M, Dzaja P, Seiwerth S, Sikiric P, Peric J, Geres D, Kos J. The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J Physiol Paris. 1997 May-Oct;91(3-5):139-49. doi: 10.1016/s0928-4257(97)89478-8. PMID: 9403788.
[vi] Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865. doi:10.2174/1570159×13666160502153022
[vii] Suran J, Kolenc D, Crnic AP, Radic B, Drmic I, et al. The effect of pentadecapeptide BPC 157 in metamphetamine-induced dopaminergic neurotoxicity (1143.11). FASEB J. 2014;28:Suppl1.
[viii] Filaretova LP, Takeuchi K (eds): Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Front Gastrointest Res. Basel, Karger, 2012, vol 30, pp 191–201. doi: 10.1159/000338435
Comments
No comments on this item Please log in to comment by clicking here